A Review of Active Surveillance of Papillary Thyroid Microcarcinoma

키워드

참고문헌 (40)

1. Annual Report of Cancer Statictics in Korea in 2018, "Korea Central Cancer Registry", Ministry of Health and Welfare, ~ (2020)
2. Davies L, "American Association of clinical endocrinologists and American College of Endocrinology disease state clinical review : the increasing incidence of thyroid cancer", Endocr Pract, 21, pp.686~696 (2015)
3. Vaccarella S, "Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis", N Engl J Med, 375, pp.614~617 (2016)
4. Gweon HM, "Predictive factors for active surveillance of subcentimeter thyroid nodules with highly suspicious US features", Ann Surg Oncol, 24, pp.1540~1545 (2017)
5. Scharpf J, "Achieving active surveillance for thyroid cancer-not a euphemism for watching a ticking time bomb", JAMA Otolaryngol Head Neck Surg, 143, pp.1021~1022 (2017)
6. Hirokawa M, "Pathological characteristics of low-risk papillary thyroid microcarcinoma with progression during active surveillance", Endocr J, 63, pp.805~810 (2016)
7. Leboulleux S, "Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?", Lancet Diabetes Endocrinol, 4, pp.933~942 (2016)
8. Ahn HS, "Korea’s thyroid-cancer"epidemic"--screening and overdiagnosis", N Engl J Med, 371, pp.1765~1767 (2014)
9. Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer", Thyroid, 26, pp.1~133 (2016)
10. Annual Report of Cancer Statistics in Korea in 2015, "Korea Central Cancer Registry", Ministry of Health and Welfare, ~ (2017)
11. Ho AS, "Parallels between low-risk prostate cancer and thyroid cancer : a review", JAMA Oncol, 5, pp.556~564 (2019)
12. Ito Y, "Trends in the implementation of active surveillance for low-risk papillary thyroid microcarcinomas at Kuma Hospital : gradual increase and heterogeneity in the acceptance of this new management option", Thyroid, 28, pp.488~495 (2018)
13. Takami H, "Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons", World J Surg, 35, pp.111~121 (2011)
14. Ito Y, "An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid", Thyroid, 13, pp.381~387 (2003)
15. Tuttle RM, "Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance", JAMA Otolaryngol Head Neck Surg, 143, pp.1015~1020 (2017)
16. Sawka AM, "A protocol for a Pan-Canadian prospective observational study on active surveillance or surgery for very low risk papillary thyroid cancer", Front Endocrinol(Lausanne), 12, pp.686996~ (2021)
17. Oh HS, "Active surveillance of low-risk papillary thyroid microcarcinoma : a multi-center cohort study in Korea", Thyroid, 28, pp.1587~1594 (2018)
18. Ito Y, "Low-risk papillary microcarcinoma of the thyroid : a review of active surveillance trials", Eur J Surg Oncol, 44, pp.307~315 (2018)
19. Ito Y, "Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation", Thyroid, 24, pp.27~34 (2014)
20. Kwon H, "Active surveillance for patients with papillary thyroid microcarcinoma : a single center’s experience in Korea", J Clin Endocrinol Metab, 102, pp.1917~1925 (2017)
21. Oh HS, "Tumor volume doubling time in active surveillance of papillary thyroid carcinoma", Thyroid, 29, pp.642~649 (2019)
22. Sugitani I, "Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized : our treatment strategies and outcomes", World J Surg, 34, pp.1222~1231 (2010)
23. Chung JH, "BRAF and TERT promoter mutations : clinical application in thyroid cancer", Endocr J, 67, pp.577~584 (2020)
24. Xing M, "BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence", J Clin Oncol, 32, pp.2718~2726 (2014)
25. Shen X, "Patient age-associated mortality risk is differentiated by BRAF V600E status in papillary thyroid cancer", J Clin Oncol, 36, pp.438~445 (2018)
26. Kim TY, "The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma", Clin Endocrinol(Oxf), 63, pp.588~593 (2005)
27. Liu RT, "No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan", Clin Endocrinol(Oxf), 63, pp.461~466 (2005)
28. Ito Y, "BRAF mutation in papillary thyroid carcinoma in a Japanese population : its lack of correlation with high-risk clinicopathological features and disease-free survival of patients", Endocr J, 56, pp.89~97 (2009)
29. Lee SE, "Prognostic significance of TERT promoter mutations in papillary thyroid carcinomas in a BRAF(V600E)mutation-prevalent population", Thyroid, 26, pp.901~910 (2016)
30. Lubitz CC, "Annual financial impact of well-differentiated thyroid cancer care in the United States", Cancer, 120, pp.1345~1352 (2014)
31. Venkatesh S, "Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer", Surgery, 161, pp.116~126 (2017)
32. Chan WL, "Health-related quality of life in Asian differentiated thyroid cancer survivors", Cancer Control, 28 (2021)
33. Lin JF, "Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance", Surgery, 167, pp.110~116 (2020)
34. 문재훈, "Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro)", Endocrinology and Metabolism, 33(2), pp.278~286 (2018), 대한내분비학회
35. Jeon MJ, "Quality of life in patients with papillary thyroid microcarcinoma managed by active surveillance or lobectomy : a cross-sectional study", Thyroid, 29, pp.956~962 (2019)
36. Kong SH, "Longitudinal assessment of quality of life according to treatment options in low-risk papillary thyroid microcarcinoma patients : active surveillance or immediate surgery(Interim Analysis of MAeSTro)", Thyroid, 29, pp.1089~1096 (2019)
37. Muhammad H, "Radiofrequency ablation and thyroid nodules : updated systematic review", Endocrine, 72, pp.619~632 (2021)
38. Zhang M, "Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma : results of over 5 years’ follow-up", Thyroid, 30, pp.408~417 (2020)
39. Ma B, "Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma by percutaneous thermal ablation : a retrospective case review and literature review", Thyroid, 28, pp.1134~1142 (2018)
40. Saravana-Bawan B, "Active surveillance of low-risk papillary thyroid cancer : a meta-analysis", Surgery, 167, pp.46~55 (2020)

관련 논문AI추천